S Jayanthi

S Jayanthi

Profile ID RP-000-5530 Joined 2023-01-22 2 articles
1
Total Views
2
Total Publications
1
Publication Views

Articles(2)

Authors: S. H. Shifa Meharaj, S. Jayanthi, D. Danisvijay, A. Sujhithra, J. Perumal

DOI: 10.18231/j.ijmmtd.2019.034  

Volume5

Issue3

Pages155-159

Abstract

Introduction: Staphylococcus aureus a Gram positive cocci causes major and minor infections in humans. It is the most important pathogen causing Hospital acquired and community-acquired (CA) infections. The commonest being the Methicillin resistant Staphylococcus aureus (MRSA) which is due to the insertion of SCC mec into methicillin-susceptible S. aureus (MSSA) lineages. Though, a number of toxins are involved in the pathogenesis of its infections, Panton Valentine leukocidin (PVL) is considered the common virulence factor for community acquired MRSA. Our study aimed to determine the prevalence of mec A and mecC gene and the presence of PVL toxin genes (lukS-PV and lukF-PV) in S. aureus isolates.  Materials and Methods: The study was carried out in Department of Microbiology at Chettinad Hospital & Research Institute, a tertiary care center for 3 months. A total of 109 clinical isolates of S.aureus were subjected for the study (Wards and Outpatient departments). The identification and antimicrobial sensitivity testing were done by standard microbiological techniques. Multiplex PCR was used to detect mecA, mecC and PVL genes. Results: Out of 109 Staphylococcus aureus isolates, 24(22%) were MRSA and 85(78%) were Methicillin sensitive. Among MRSA strains, 13(54.1%) were positive for mecA, 8(33.3%) were positive for PVL, 3 (12.5%) were found positive for mecC. Among the 85(78%) MSSA isolates, 3(3.5%) were positive mecA gene and only 1(1.1%) isolate had mecC gene. The isolates from hospital environment were negative for both mecA and mecC but was positive for PVL genes. Conclusion: Our study showed high prevalence among community acquired MRSA isolates. Keywords: Community acquired staphylococcus aureus, MRSA, mecA, mec C, PVL gene, Multiplex PCR.

View Article

Authors: D. Danis Vijay, S. Jayanthi, N. Meenakshi

DOI: 10.18231/2394-5478.2018.0089  

Volume5

Issue4

Pages430-435

Abstract

Pneumonia exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for antibiotic therapy modifications as well as diagnosis, prognosis and follow-up treatment of pneumonia. This review presents the biological and clinical features of various biomarkers in Pneumonia patients, including C-reactive protein, Procalcitonin, Coceptin, D-dimers, MRpro-ADM, (Mid-regional pro adrenomedullin), Corisol, Endothelin-1, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), Adrenomedullin, Endotoxin, Mid regional Pro-Atrial Natriuretic Peptide (MR-proANP), TNF-? Polymorphisms, Pentraxin 3. Keywords: Pneumonia, Community-acquired, Hospital-acquired, Ventilator-associated pneumonia (VAP), Biomarkers, Point of care testing.

View Article

No matching articles

Try another word from the title, author or DOI.